![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 06, 2010 4:45:24 PM
March 16, 2009
By a GenomeWeb staff reporter
Type size: - + Email Printer-friendly version RSS Feed NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against DNAPrint Genomics and its Ellipsis Biotherapeutics subsidiary seeking payment for products Illumina shipped to the firm in 2007-2008.
According to the suit, which was filed last week in the US District Court for the Southern District of California, Illumina is seeking nearly $275,000 in payments from DNAPrint Genomics for genotyping kits and DNA analysis kits that it ordered from Illumina and didn't pay for, as stipulated under a contract between the firms in April 2007.
As reported by GenomeWeb Daily News two weeks ago, DNAPrint Genomics shut down its operations sometime in February or early March.
Between December 2006 and June 2008, DNAPrint entered into nine separate purchase order contracts with Illumina. The suit alleges that although Illumina provided all of the products under the agreements, DNAPrint never made payments on the products.
Illumina has demanded a jury trial seeking payment of the full amount due, plus interest and the award of attorneys' fees
[color=red][/color]
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM